Stocks
Sanofi (SNY) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 29.5% | 31.0% | 31.5% | 30.1% | 27.4% | 15.4% | ||
| Changes by years, y/y, % | +2pp | +2pp | +1pp | -1pp | -3pp | -2.7% | |||
Sanofi. EBITDA margin, %
Sanofi. EBITDA margin, changes, pp
Sanofi (SNY) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA margin, % | ? | 33.9% | 7.19% | 25.8% | 19.4% | 17.8% | 15.4% | |
| Changes by years, y/y, % | +8pp | -19pp | -5pp | -12pp | -5pp | |||
| Changes by quarters, q/q, % | +3pp | -27pp | +19pp | -6pp | -2pp | |||
